Gender differences in Parkinson's disease: Clinical characteristics and cognition
Identifieur interne : 000306 ( Istex/Corpus ); précédent : 000305; suivant : 000307Gender differences in Parkinson's disease: Clinical characteristics and cognition
Auteurs : Ivy N. Miller ; Alice Cronin-GolombSource :
- Movement Disorders [ 0885-3185 ] ; 2010-12-15.
Abstract
More men than women are diagnosed with Parkinson's disease (PD), and a number of gender differences have been documented in this disorder. Examples of clinical characteristics that appear in men more often than women include rigidity and rapid eye movement behavior disorder, whereas more women than men exhibit dyskinesias and depression. Differences between men and women in cognition have not been extensively examined, though there are reports of deficits in men in aspects of cognition that contribute to activities of daily living, in verbal fluency, and in the recognition of facial emotion, and deficits in women in visuospatial cognition. Side of disease onset may interact with gender to affect cognitive abilities. One possible source of male‐female differences in the clinical and cognitive characteristics of PD is the effect of estrogen on dopaminergic neurons and pathways in the brain. This effect is not yet understood, as insight into how the fluctuation of estrogen over the lifetime affects the brain is currently limited. Further attention to this area of research will be important for accurate assessment and better management of PD. Attention should also be directed to multiple covariates that may affect clinical characteristics and cognition. Knowledge about differences in the presentation of PD symptoms in men and women and about the pathophysiology underlying those differences may enhance the accuracy and effectiveness of clinical assessment and treatment of the disease. © 2010 Movement Disorder Society
Url:
DOI: 10.1002/mds.23388
Links to Exploration step
ISTEX:AE0F93818A8DBDF685547661EEDBA10B81BBABFCLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Gender differences in Parkinson's disease: Clinical characteristics and cognition</title><author><name sortKey="Miller, Ivy N" sort="Miller, Ivy N" uniqKey="Miller I" first="Ivy N." last="Miller">Ivy N. Miller</name><affiliation><mods:affiliation>Department of Psychology, Boston University, Boston, Massachusetts, USA</mods:affiliation></affiliation></author><author><name sortKey="Cronin Olomb, Alice" sort="Cronin Olomb, Alice" uniqKey="Cronin Olomb A" first="Alice" last="Cronin-Golomb">Alice Cronin-Golomb</name><affiliation><mods:affiliation>Department of Psychology, Boston University, Boston, Massachusetts, USA</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:AE0F93818A8DBDF685547661EEDBA10B81BBABFC</idno><date when="2010" year="2010">2010</date><idno type="doi">10.1002/mds.23388</idno><idno type="url">https://api.istex.fr/document/AE0F93818A8DBDF685547661EEDBA10B81BBABFC/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">000306</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Gender differences in Parkinson's disease: Clinical characteristics and cognition</title><author><name sortKey="Miller, Ivy N" sort="Miller, Ivy N" uniqKey="Miller I" first="Ivy N." last="Miller">Ivy N. Miller</name><affiliation><mods:affiliation>Department of Psychology, Boston University, Boston, Massachusetts, USA</mods:affiliation></affiliation></author><author><name sortKey="Cronin Olomb, Alice" sort="Cronin Olomb, Alice" uniqKey="Cronin Olomb A" first="Alice" last="Cronin-Golomb">Alice Cronin-Golomb</name><affiliation><mods:affiliation>Department of Psychology, Boston University, Boston, Massachusetts, USA</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2010-12-15">2010-12-15</date><biblScope unit="vol">25</biblScope><biblScope unit="issue">16</biblScope><biblScope unit="page" from="2695">2695</biblScope><biblScope unit="page" to="2703">2703</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">AE0F93818A8DBDF685547661EEDBA10B81BBABFC</idno><idno type="DOI">10.1002/mds.23388</idno><idno type="ArticleID">MDS23388</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">More men than women are diagnosed with Parkinson's disease (PD), and a number of gender differences have been documented in this disorder. Examples of clinical characteristics that appear in men more often than women include rigidity and rapid eye movement behavior disorder, whereas more women than men exhibit dyskinesias and depression. Differences between men and women in cognition have not been extensively examined, though there are reports of deficits in men in aspects of cognition that contribute to activities of daily living, in verbal fluency, and in the recognition of facial emotion, and deficits in women in visuospatial cognition. Side of disease onset may interact with gender to affect cognitive abilities. One possible source of male‐female differences in the clinical and cognitive characteristics of PD is the effect of estrogen on dopaminergic neurons and pathways in the brain. This effect is not yet understood, as insight into how the fluctuation of estrogen over the lifetime affects the brain is currently limited. Further attention to this area of research will be important for accurate assessment and better management of PD. Attention should also be directed to multiple covariates that may affect clinical characteristics and cognition. Knowledge about differences in the presentation of PD symptoms in men and women and about the pathophysiology underlying those differences may enhance the accuracy and effectiveness of clinical assessment and treatment of the disease. © 2010 Movement Disorder Society</div></front></TEI><istex><corpusName>wiley</corpusName><author><json:item><name>Ivy N. Miller MA</name><affiliations><json:string>Department of Psychology, Boston University, Boston, Massachusetts, USA</json:string></affiliations></json:item><json:item><name>Alice Cronin‐Golomb PhD</name><affiliations><json:string>Department of Psychology, Boston University, Boston, Massachusetts, USA</json:string></affiliations></json:item></author><genre><json:string>Serial article</json:string></genre><host><volume>25</volume><pages><total>9</total><last>2703</last><first>2695</first></pages><issn><json:string>0885-3185</json:string></issn><issue>16</issue><subject><json:item><value>Review</value></json:item></subject><genre></genre><language><json:string>unknown</json:string></language><title>Movement Disorders</title><doi><json:string>10.1002/(ISSN)1531-8257</json:string></doi></host><language><json:string>eng</json:string></language><abstract>More men than women are diagnosed with Parkinson's disease (PD), and a number of gender differences have been documented in this disorder. Examples of clinical characteristics that appear in men more often than women include rigidity and rapid eye movement behavior disorder, whereas more women than men exhibit dyskinesias and depression. Differences between men and women in cognition have not been extensively examined, though there are reports of deficits in men in aspects of cognition that contribute to activities of daily living, in verbal fluency, and in the recognition of facial emotion, and deficits in women in visuospatial cognition. Side of disease onset may interact with gender to affect cognitive abilities. One possible source of male‐female differences in the clinical and cognitive characteristics of PD is the effect of estrogen on dopaminergic neurons and pathways in the brain. This effect is not yet understood, as insight into how the fluctuation of estrogen over the lifetime affects the brain is currently limited. Further attention to this area of research will be important for accurate assessment and better management of PD. Attention should also be directed to multiple covariates that may affect clinical characteristics and cognition. Knowledge about differences in the presentation of PD symptoms in men and women and about the pathophysiology underlying those differences may enhance the accuracy and effectiveness of clinical assessment and treatment of the disease. © 2010 Movement Disorder Society</abstract><qualityIndicators><score>7.796</score><pdfVersion>1.3</pdfVersion><pdfPageSize>612 x 810 pts</pdfPageSize><refBibsNative>true</refBibsNative><abstractCharCount>1537</abstractCharCount><pdfWordCount>5239</pdfWordCount><pdfCharCount>34872</pdfCharCount><pdfPageCount>9</pdfPageCount><abstractWordCount>233</abstractWordCount></qualityIndicators><title>Gender differences in Parkinson's disease: Clinical characteristics and cognition</title><publicationDate>2010</publicationDate><copyrightDate>2010</copyrightDate><doi><json:string>10.1002/mds.23388</json:string></doi><id>AE0F93818A8DBDF685547661EEDBA10B81BBABFC</id><fulltext><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/AE0F93818A8DBDF685547661EEDBA10B81BBABFC/fulltext/pdf</uri></json:item><json:item><original>false</original><mimetype>application/zip</mimetype><extension>zip</extension><uri>https://api.istex.fr/document/AE0F93818A8DBDF685547661EEDBA10B81BBABFC/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/AE0F93818A8DBDF685547661EEDBA10B81BBABFC/fulltext/tei"><teiHeader type="text"><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Gender differences in Parkinson's disease: Clinical characteristics and cognition</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><availability><p>Wiley Subscription Services, Inc., A Wiley Company</p></availability><date>2010</date></publicationStmt><notesStmt><note type="content">*Potential conflict of interest: The authors report no conflicts of interest.</note><note>Boston University (I.N.M.) - No. 1 R01 NS050446‐01;</note><note>National Institute of Neurological Disorders and Stroke (A.C.G.)</note></notesStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Gender differences in Parkinson's disease: Clinical characteristics and cognition</title><author><persName><forename type="first">Ivy N.</forename><surname>Miller</surname><roleName type="degree">MA</roleName></persName><affiliation>Department of Psychology, Boston University, Boston, Massachusetts, USA</affiliation></author><author><persName><forename type="first">Alice</forename><surname>Cronin‐Golomb</surname><roleName type="degree">PhD</roleName></persName><note type="correspondence"><p>Correspondence: Department of Psychology, Boston University, 648 Beacon Street, 2nd floor, Boston MA, USA 02215</p></note><affiliation>Department of Psychology, Boston University, Boston, Massachusetts, USA</affiliation></author></analytic><monogr><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="pISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><idno type="DOI">10.1002/(ISSN)1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2010-12-15"></date><biblScope unit="vol">25</biblScope><biblScope unit="issue">16</biblScope><biblScope unit="page" from="2695">2695</biblScope><biblScope unit="page" to="2703">2703</biblScope></imprint></monogr><idno type="istex">AE0F93818A8DBDF685547661EEDBA10B81BBABFC</idno><idno type="DOI">10.1002/mds.23388</idno><idno type="ArticleID">MDS23388</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>2010</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>More men than women are diagnosed with Parkinson's disease (PD), and a number of gender differences have been documented in this disorder. Examples of clinical characteristics that appear in men more often than women include rigidity and rapid eye movement behavior disorder, whereas more women than men exhibit dyskinesias and depression. Differences between men and women in cognition have not been extensively examined, though there are reports of deficits in men in aspects of cognition that contribute to activities of daily living, in verbal fluency, and in the recognition of facial emotion, and deficits in women in visuospatial cognition. Side of disease onset may interact with gender to affect cognitive abilities. One possible source of male‐female differences in the clinical and cognitive characteristics of PD is the effect of estrogen on dopaminergic neurons and pathways in the brain. This effect is not yet understood, as insight into how the fluctuation of estrogen over the lifetime affects the brain is currently limited. Further attention to this area of research will be important for accurate assessment and better management of PD. Attention should also be directed to multiple covariates that may affect clinical characteristics and cognition. Knowledge about differences in the presentation of PD symptoms in men and women and about the pathophysiology underlying those differences may enhance the accuracy and effectiveness of clinical assessment and treatment of the disease. © 2010 Movement Disorder Society</p></abstract><textClass><keywords scheme="Journal Subject"><list><head>Article category</head><item><term>Review</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="2010-11-11">Received</change><change when="2010-07-13">Registration</change><change when="2010-12-15">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><original>false</original><mimetype>text/plain</mimetype><extension>txt</extension><uri>https://api.istex.fr/document/AE0F93818A8DBDF685547661EEDBA10B81BBABFC/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Wiley Subscription Services, Inc., A Wiley Company</publisherName><publisherLoc>Hoboken</publisherLoc></publisherInfo><doi registered="yes">10.1002/(ISSN)1531-8257</doi><issn type="print">0885-3185</issn><issn type="electronic">1531-8257</issn><idGroup><id type="product" value="MDS"></id></idGroup><titleGroup><title type="main" xml:lang="en" sort="MOVEMENT DISORDERS">Movement Disorders</title><title type="short">Mov. Disord.</title></titleGroup></publicationMeta><publicationMeta level="part" position="160"><doi origin="wiley" registered="yes">10.1002/mds.v25.16</doi><numberingGroup><numbering type="journalVolume" number="25">25</numbering><numbering type="journalIssue">16</numbering></numberingGroup><coverDate startDate="2010-12-15">15 December 2010</coverDate></publicationMeta><publicationMeta level="unit" type="reviewArticle" position="10" status="forIssue"><doi origin="wiley" registered="yes">10.1002/mds.23388</doi><idGroup><id type="unit" value="MDS23388"></id></idGroup><countGroup><count type="pageTotal" number="9"></count></countGroup><titleGroup><title type="articleCategory">Review</title><title type="tocHeading1">Reviews</title></titleGroup><copyright ownership="thirdParty">Copyright © 2010 Movement Disorder Society</copyright><eventGroup><event type="manuscriptRevised" date="2010-03-16"></event><event type="manuscriptAccepted" date="2010-07-13"></event><event type="manuscriptReceived" date="2010-11-11"></event><event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.4 mode:FullText" date="2010-12-16"></event><event type="publishedOnlineEarlyUnpaginated" date="2010-10-05"></event><event type="firstOnline" date="2010-10-05"></event><event type="publishedOnlineFinalForm" date="2010-12-16"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-02"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-31"></event></eventGroup><numberingGroup><numbering type="pageFirst">2695</numbering><numbering type="pageLast">2703</numbering></numberingGroup><correspondenceTo>Department of Psychology, Boston University, 648 Beacon Street, 2nd floor, Boston MA, USA 02215</correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:MDS.MDS23388.pdf"></link></linkGroup></publicationMeta><contentMeta><countGroup><count type="figureTotal" number="0"></count><count type="tableTotal" number="2"></count><count type="referenceTotal" number="62"></count><count type="wordTotal" number="6738"></count></countGroup><titleGroup><title type="main" xml:lang="en">Gender differences in Parkinson's disease: Clinical characteristics and cognition<link href="#fn2"></link></title><title type="short" xml:lang="en">Gender Differences in Parkinson's disease</title></titleGroup><creators><creator xml:id="au1" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Ivy N.</givenNames><familyName>Miller</familyName><degrees>MA</degrees></personName></creator><creator xml:id="au2" creatorRole="author" affiliationRef="#af1" corresponding="yes"><personName><givenNames>Alice</givenNames><familyName>Cronin‐Golomb</familyName><degrees>PhD</degrees></personName><contactDetails><email>alicecg@bu.edu</email></contactDetails></creator></creators><affiliationGroup><affiliation xml:id="af1" countryCode="US" type="organization"><unparsedAffiliation>Department of Psychology, Boston University, Boston, Massachusetts, USA</unparsedAffiliation></affiliation></affiliationGroup><fundingInfo><fundingAgency>Boston University (I.N.M.)</fundingAgency><fundingNumber>1 R01 NS050446‐01</fundingNumber></fundingInfo><fundingInfo><fundingAgency>National Institute of Neurological Disorders and Stroke (A.C.G.)</fundingAgency></fundingInfo><abstractGroup><abstract type="main" xml:lang="en"><title type="main">Abstract</title><p>More men than women are diagnosed with Parkinson's disease (PD), and a number of gender differences have been documented in this disorder. Examples of clinical characteristics that appear in men more often than women include rigidity and rapid eye movement behavior disorder, whereas more women than men exhibit dyskinesias and depression. Differences between men and women in cognition have not been extensively examined, though there are reports of deficits in men in aspects of cognition that contribute to activities of daily living, in verbal fluency, and in the recognition of facial emotion, and deficits in women in visuospatial cognition. Side of disease onset may interact with gender to affect cognitive abilities. One possible source of male‐female differences in the clinical and cognitive characteristics of PD is the effect of estrogen on dopaminergic neurons and pathways in the brain. This effect is not yet understood, as insight into how the fluctuation of estrogen over the lifetime affects the brain is currently limited. Further attention to this area of research will be important for accurate assessment and better management of PD. Attention should also be directed to multiple covariates that may affect clinical characteristics and cognition. Knowledge about differences in the presentation of PD symptoms in men and women and about the pathophysiology underlying those differences may enhance the accuracy and effectiveness of clinical assessment and treatment of the disease. © 2010 Movement Disorder Society</p></abstract></abstractGroup></contentMeta><noteGroup><note xml:id="fn2"><p>Potential conflict of interest: The authors report no conflicts of interest.</p></note></noteGroup></header></component></istex:document></istex:metadataXml><!--Version 0.6 générée le 3-12-2015--><mods version="3.6"><titleInfo lang="en"><title>Gender differences in Parkinson's disease: Clinical characteristics and cognition</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>Gender Differences in Parkinson's disease</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Gender differences in Parkinson's disease: Clinical characteristics and cognition</title></titleInfo><name type="personal"><namePart type="given">Ivy N.</namePart><namePart type="family">Miller</namePart><namePart type="termsOfAddress">MA</namePart><affiliation>Department of Psychology, Boston University, Boston, Massachusetts, USA</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Alice</namePart><namePart type="family">Cronin‐Golomb</namePart><namePart type="termsOfAddress">PhD</namePart><affiliation>Department of Psychology, Boston University, Boston, Massachusetts, USA</affiliation><description>Correspondence: Department of Psychology, Boston University, 648 Beacon Street, 2nd floor, Boston MA, USA 02215</description><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre authority="originalCategForm">reviewArticle</genre><originInfo><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><place><placeTerm type="text">Hoboken</placeTerm></place><dateIssued encoding="w3cdtf">2010-12-15</dateIssued><dateCaptured encoding="w3cdtf">2010-11-11</dateCaptured><dateValid encoding="w3cdtf">2010-07-13</dateValid><copyrightDate encoding="w3cdtf">2010</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType><extent unit="tables">2</extent><extent unit="references">62</extent><extent unit="words">6738</extent></physicalDescription><abstract lang="en">More men than women are diagnosed with Parkinson's disease (PD), and a number of gender differences have been documented in this disorder. Examples of clinical characteristics that appear in men more often than women include rigidity and rapid eye movement behavior disorder, whereas more women than men exhibit dyskinesias and depression. Differences between men and women in cognition have not been extensively examined, though there are reports of deficits in men in aspects of cognition that contribute to activities of daily living, in verbal fluency, and in the recognition of facial emotion, and deficits in women in visuospatial cognition. Side of disease onset may interact with gender to affect cognitive abilities. One possible source of male‐female differences in the clinical and cognitive characteristics of PD is the effect of estrogen on dopaminergic neurons and pathways in the brain. This effect is not yet understood, as insight into how the fluctuation of estrogen over the lifetime affects the brain is currently limited. Further attention to this area of research will be important for accurate assessment and better management of PD. Attention should also be directed to multiple covariates that may affect clinical characteristics and cognition. Knowledge about differences in the presentation of PD symptoms in men and women and about the pathophysiology underlying those differences may enhance the accuracy and effectiveness of clinical assessment and treatment of the disease. © 2010 Movement Disorder Society</abstract><note type="content">*Potential conflict of interest: The authors report no conflicts of interest.</note><note type="funding">Boston University (I.N.M.) - No. 1 R01 NS050446‐01; </note><note type="funding">National Institute of Neurological Disorders and Stroke (A.C.G.)</note><relatedItem type="host"><titleInfo><title>Movement Disorders</title></titleInfo><titleInfo type="abbreviated"><title>Mov. Disord.</title></titleInfo><subject><genre>article category</genre><topic>Review</topic></subject><identifier type="ISSN">0885-3185</identifier><identifier type="eISSN">1531-8257</identifier><identifier type="DOI">10.1002/(ISSN)1531-8257</identifier><identifier type="PublisherID">MDS</identifier><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>25</number></detail><detail type="issue"><caption>no.</caption><number>16</number></detail><extent unit="pages"><start>2695</start><end>2703</end><total>9</total></extent></part></relatedItem><identifier type="istex">AE0F93818A8DBDF685547661EEDBA10B81BBABFC</identifier><identifier type="DOI">10.1002/mds.23388</identifier><identifier type="ArticleID">MDS23388</identifier><accessCondition type="use and reproduction" contentType="copyright">Copyright © 2010 Movement Disorder Society</accessCondition><recordInfo><recordOrigin>Wiley Subscription Services, Inc., A Wiley Company</recordOrigin><recordContentSource>WILEY</recordContentSource></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000306 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 000306 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:AE0F93818A8DBDF685547661EEDBA10B81BBABFC
|texte= Gender differences in Parkinson's disease: Clinical characteristics and cognition
}}
| This area was generated with Dilib version V0.6.23. |  |